Celularity Inc. (CELU)
Largest Insider Buys in Sector
CELU Stock Price History Chart
CELU Stock Performance
About Celularity Inc.
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to …
Insider Activity of Celularity Inc.
Over the last 12 months, insiders at Celularity Inc. have bought $5.33M and sold $0 worth of Celularity Inc. stock.
On average, over the past 5 years, insiders at Celularity Inc. have bought $2.82M and sold $23.06M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Lim Kok Thay (10 percent owner) — $5.33M.
The last purchase of 21,410,983 shares for transaction amount of $5.33M was made by Lim Kok Thay (10 percent owner) on 2024‑01‑12.
List of Insider Buy and Sell Transactions, Celularity Inc.
| 2024-01-12 | 10 percent owner | 21.41M 11.8762% | $0.25 | $5.33M | +39.40% | |||
| 2023-10-05 | Sale | 10 percent owner | 6.31M 21.0749% | $1.50 | $9.46M | +42.18% | ||
| 2023-10-05 | Chief Executive Officer | 9.36M 3.306% | $0.16 | $1.48M | +42.18% | |||
| 2023-09-29 | Sale | 10 percent owner | 9.06M 30.2885% | $1.50 | $13.6M | +35.14% | ||
| 2023-09-29 | Chief Executive Officer | 9.06M 3.3418% | $0.17 | $1.5M | +35.14% | |||
| 2022-11-30 | Chief Executive Officer | 10,000 0.0383% | $1.72 | $17,175 | -66.08% | |||
| 2022-11-29 | Chief Executive Officer | 40,000 0.1524% | $1.71 | $68,400 | -65.27% | |||
| 2022-11-28 | Chief Executive Officer | 40,000 0.155% | $1.74 | $69,600 | -64.36% |
Insider Historical Profitability
| Lim Kok Thay | 10 percent owner | 51473762 228.933% | $2.28 | 1 | 0 | |
| Hariri Robert J | Chief Executive Officer | 28570434 127.0689% | $2.28 | 5 | 0 | <0.0001% |